A. Belenkov

Polyethyleneimine grafted with pluronic P85 enhances Ku86 antisense delivery and the ionizing radiation treatment efficacy in vivo

T. Chow, B. Monia, A. Belenkov, 2004, Gene Therapy.

An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents.

T. Chow, B. Monia, A. Belenkov, 2002, Cancer research.

Cross-Linking Agents Ionizing Radiation , Bleomycin , and Etoposide but not DNA Messenger RNA Sensitizes M 059 K Malignant Glioma Cells to An Antisense Oligonucleotide Targeted to Human Ku 86 Updated

T. Chow, B. Monia, A. Belenkov, 2002 .

In Vivo Optical Imaging of Acute Myeloid Leukemia by Green Fluorescent Protein: Time-Domain Autofluorescence Decoupling, Fluorophore Quantification, and Localization

B. Gjertsen, J. Lorens, A. Belenkov, 2007, Molecular imaging.

Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin.

T. Chow, G. Shenouda, A. Belenkov, 2004, Molecular cancer therapeutics.

Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma

T. Chow, G. Shenouda, A. Belenkov, 2004, International Journal of Gynecologic Cancer.

Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

A. Belenkov, L. Panasci, R. Aloyz, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.